Elodie Belnoue

Title: Elodie Belnoue: Innovator in Cancer Treatment

Introduction

Elodie Belnoue is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 6 patents, her work focuses on developing novel therapeutic approaches for various types of cancer.

Latest Patents

Among her latest patents, Elodie has developed a complex comprising a cell penetrating peptide, a cargo, and a TLR peptide agonist for the treatment of glioblastoma. This invention provides a novel complex aimed at the prevention and treatment of glioma, particularly glioblastoma. The complex includes a cell penetrating peptide, at least one antigen or antigenic epitope, and at least one TLR peptide agonist, with all components covalently linked. Additionally, she has created a similar complex for the treatment of colorectal cancer, which also includes a cell penetrating peptide, an antigen, and a TLR peptide agonist, designed for use in pharmaceutical compositions and vaccines.

Career Highlights

Elodie is currently associated with Amal Therapeutics SA, where she continues to advance her research in cancer therapies. Her innovative work has positioned her as a key figure in the development of new treatment modalities.

Collaborations

Elodie collaborates with Madiha Derouazi, who is also a notable figure in the field. Together, they work towards enhancing the efficacy of cancer treatments through their combined expertise.

Conclusion

Elodie Belnoue's contributions to cancer treatment through her patented inventions highlight her role as a leading innovator in the field. Her work continues to pave the way for new therapeutic options for patients suffering from various forms of cancer.